{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:49Z","timestamp":1786119589758,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/jcp.0b013e318267062c","type":"journal-article","created":{"date-parts":[[2012,8,25]],"date-time":"2012-08-25T02:44:07Z","timestamp":1345862647000},"page":"719-720","source":"Crossref","is-referenced-by-count":7,"title":["Ropinirole as an Effective Adjunctive Treatment for Clozapine-Resistant Negative Symptoms in Simple Schizophrenia"],"prefix":"10.1097","volume":"32","author":[{"given":"Panayiota G.","family":"Michalopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Azim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhwinder S.","family":"Shergill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210128","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0010-440X(90)90041-P","article-title":"Simple schizophrenia: revisited.","volume":"31","author":"Black","year":"1990","journal-title":"Compr Psychiatry"},{"key":"R2-24-20210128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/schbul\/sbj053","article-title":". The NIMH-MATRICS consensus statement on negative symptoms.","volume":"32","author":"Kirkpatrick","year":"2006","journal-title":"Schizophr Bull"},{"key":"R3-24-20210128","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mds.21949","article-title":". Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom.","volume":"23","author":"Czernecki","year":"2008","journal-title":"Mov Disord"},{"key":"R4-24-20210128","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia. Definition and reliability.","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"R5-24-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1176\/jnp.3.3.243","article-title":"Apathy: a neuropsychiatric syndrome.","volume":"3","author":"Marin","year":"1991","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R6-24-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1527-3458.2005.tb00046.x","article-title":"Ropinirole, a non-ergoline dopamine agonist.","volume":"11","author":"Jost","year":"2005","journal-title":"CNS Drug Rev"},{"key":"R7-24-20210128","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/WNL.53.2.364","article-title":". A 3-year randomized trial of ropinirole and bromocriptine in early Parkinsons disease. The 053 Study Group.","volume":"53","author":"Korczyn","year":"1999","journal-title":"Neurology"},{"key":"R8-24-20210128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00013-C","article-title":"Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground.","volume":"16","author":"Weinberger","year":"1995","journal-title":"Schizophr Res"},{"key":"R9-24-20210128","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00213-006-0405-4","article-title":". Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.","volume":"187","author":"Juckel","year":"2006","journal-title":"Psychopharmacology"},{"key":"R10-24-20210128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1176\/ajp.155.6.751","article-title":". Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.","volume":"155","author":"Buchanan","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R11-24-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.159.2.255","article-title":". Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.","volume":"159","author":"Volavka","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R12-24-20210128","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00004714-200112000-00011","article-title":". Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.","volume":"21","author":"Ozdemir","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R13-24-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0447.2011.01710.x","article-title":". Optimizing clozapine treatment.","volume":"123","author":"Nielsen","year":"2011","journal-title":"Acta Psychiatr Scand"},{"key":"R14-24-20210128","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00005053-200111000-00006","article-title":". Impact of clozapine prescription on inpatient resource utilization.","volume":"189","author":"Sernyak","year":"2001","journal-title":"J Nerv Ment Dis"},{"key":"R15-24-20210128","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/oxfordjournals.schbul.a006901","article-title":". When symptoms persist: clozapine augmentation strategies.","volume":"27","author":"Buckley","year":"2001","journal-title":"Schizophr Bull"},{"key":"R16-24-20210128","first-page":"840","article-title":"In vitro identification of the P450 enzymes responsible for the metabolism of ropinirole.","volume":"25","author":"Bloomer","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"R17-24-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002280050632","article-title":". Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinsons disease.","volume":"55","author":"Thalamas","year":"1999","journal-title":"Eur J Clin Pharmaco"},{"key":"R18-24-20210128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.schres.2008.12.002","article-title":". Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial.","volume":"108","author":"Joffe","year":"2009","journal-title":"Schizophr Res"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e318267062c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:38:57Z","timestamp":1786041537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201210000-00024"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318267062c","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}